Impact of the De-escalation of Supportive Therapies in Patients with Cystic Fibrosis Taking Elexacaftor, Tezacaftor, Ivacaftor
Autoimmunity (a condition where the body's immune system mistakes its own healthy tissues as foreign and attacks them) in People with Cystic Fibrosis
A letter in response to the recently published article entitled “Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis
Association between nebulizer therapies adherence and visit-to-visit variability of lung function in patients with cystic fibrosis
What do dietitians, doctors and physiotherapists think about the management of people with CF who are living with overweight and obesity?
More favorable growth profiles in early childhood are associated with higher lung function at age six
